KP Tissue Financials
| KPT Stock | CAD 10.45 0.22 2.15% |
KPT |
KP Tissue Stock Summary
KP Tissue competes with Organto Foods, Pesorama, Swiss Water, and Big Rock. KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in North America. KP Tissue Inc. was founded in 2012 and is headquartered in Mississauga, Canada. KP TISSUE operates under Household Personal Products classification in Canada and is traded on Toronto Stock Exchange.| Foreign Associate | USA |
Specialization | Consumer Defensive, Household & Personal Products |
| Instrument | Canada Stock View All |
| Exchange | Toronto Exchange |
| ISIN | CA48265Y1043 |
| Business Address | 2 Prologis Boulevard, |
| Sector | Personal Care Products |
| Industry | Consumer Staples |
| Benchmark | Dow Jones Industrial |
| Website | www.kptissueinc.com |
| Phone | 905 812 6900 |
| Currency | CAD - Canadian Dollar |
You should never invest in KP Tissue without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of KPT Stock, because this is throwing your money away. Analyzing the key information contained in KP Tissue's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
KP Tissue Key Financial Ratios
KP Tissue's financial ratios allow both analysts and investors to convert raw data from KP Tissue's financial statements into concise, actionable information that can be used to evaluate the performance of KP Tissue over time and compare it to other companies across industries.KPT Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining KP Tissue's current stock value. Our valuation model uses many indicators to compare KP Tissue value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across KP Tissue competition to find correlations between indicators driving KP Tissue's intrinsic value. More Info.KP Tissue is currently regarded as number one stock in return on equity category among its peers. It is rated fifth overall in current valuation category among its peers reporting about 1,884,419,117 of Current Valuation per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value KP Tissue by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for KP Tissue's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.KP Tissue Systematic Risk
KP Tissue's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. KP Tissue volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was sixty with a total number of output elements of one. The Beta measures systematic risk based on how returns on KP Tissue correlated with the market. If Beta is less than 0 KP Tissue generally moves in the opposite direction as compared to the market. If KP Tissue Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one KP Tissue is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of KP Tissue is generally in the same direction as the market. If Beta > 1 KP Tissue moves generally in the same direction as, but more than the movement of the benchmark.
KP Tissue December 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of KP Tissue help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of KP Tissue. We use our internally-developed statistical techniques to arrive at the intrinsic value of KP Tissue based on widely used predictive technical indicators. In general, we focus on analyzing KPT Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build KP Tissue's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.6933 | |||
| Information Ratio | 0.0617 | |||
| Maximum Drawdown | 4.18 | |||
| Value At Risk | (1.17) | |||
| Potential Upside | 2.08 |
Other Information on Investing in KPT Stock
KP Tissue financial ratios help investors to determine whether KPT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KPT with respect to the benefits of owning KP Tissue security.